Saltzman family gains $18.8 million as Dis-Chem shares climb
South Africa’s Saltzman family controls a 29.3 percent stake, equivalent to 302,066,319 ordinary shares in the Gauteng-based company.
South Africa’s Saltzman family controls a 29.3 percent stake, equivalent to 302,066,319 ordinary shares in the Gauteng-based company.
The Saltzman family, renowned South African billionaires and founders of Dis-Chem Pharmacies, has enhanced its integrated healthcare program through a binding Share Subscription Agreement (SSA) with OneSpark Proprietary Limited and OneSpark Holdings Inc., a Delaware-incorporated corporation.
The South African billionaire Saltzman family holds a 35.1 percent stake in the company, valued at R9.97 billion ($529.23 million).
The Saltzman family, who own 35.12 percent of Dis-Chem, played a key role in steering its growth into one of South Africa’s largest retail pharmacy chains.
South African billionaire Saltzman family presently owns a beneficial 35.12-percent stake in Dis-Chem Pharmacies.
Saltzman and his wife own a 35.12-percent stake in Dis-Chem Pharmacies, a Gauteng-based retail pharmacy chain.
Billionaires.Africa shines a spotlight on five South African trailblazers who have propelled South Africa onto the global stage of medical innovation.
Billionaires.Africa has identified seven companies with direct or indirect interests associated with the Saltzman family.
Lynette and Ivan Saltzman, who established Dis-Chem Pharmacies in 1978, presently hold a beneficial 35.15-percent stake in the healthcare giant.
Dis-Chem’s founder and long-time steps down; CFO Rui Morais to become CEO in July.
Dis-Chem Pharmacies is a high-performing pharmacy and healthcare group in South Africa.
The payment will be made as part of the healthcare firm’s insurance coverage in South Africa.
The Saltzman family owns a beneficial 45.2-percent share in the healthcare company.
Dis-Chem Pharmacies is a leading pharmacy retail and healthcare group based in South Africa.